Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IGF1R | P08069 | 7/20 | 0.79 |
| ▸ | ALOX15 | P16050 | 7/20 | 0.79 |
| ▸ | IAPP | P10997 | 1/20 | 0.64 |
| ▸ | KAT8 | Q9H7Z6 | 2/20 | 0.62 |
| ▸ | PPARA | Q07869 | 1/20 | 0.62 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.59 |
| ▸ | HIF1A | Q16665 | 2/20 | 0.59 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.59 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.59 |
| ▸ | DRD2 | P14416 | 1/20 | 0.59 |
| ▸ | TSHR | P16473 | 1/20 | 0.59 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.59 |
| ▸ | DRD1 | P21728 | 1/20 | 0.59 |
| ▸ | DRD4 | P21917 | 1/20 | 0.59 |
| ▸ | DRD5 | P21918 | 1/20 | 0.59 |
| ▸ | ADRA1D | P25100 | 1/20 | 0.59 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.59 |
| ▸ | ADRA1B | P35368 | 1/20 | 0.59 |
| ▸ | DRD3 | P35462 | 1/20 | 0.59 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.59 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL38660230 | 0.98 | IGF1R (0.76) | IGF1RALOX15IAPPKAT8PPARA | |
| SCHEMBL10352944 | 0.98 | IGF1R (0.76) | IGF1RALOX15IAPPKAT8PPARA | |
| SCHEMBL7761737 | 0.98 | IGF1R (0.76) | IGF1RALOX15IAPPKAT8PPARA | |
| SCHEMBL2782711 | 0.98 | IGF1R (0.76) | IGF1RALOX15IAPPKAT8PPARA | |
| SCHEMBL9447274 | 0.98 | IGF1R (0.76) | IGF1RALOX15IAPPKAT8PPARA | |
| SCHEMBL11616856 | 0.98 | IGF1R (0.76) | IGF1RALOX15IAPPKAT8PPARA | |
| SCHEMBL70343 | 0.98 | IGF1R (0.76) | IGF1RALOX15IAPPKAT8PPARA | |
| SCHEMBL68207 | 0.98 | IGF1R (0.76) | IGF1RALOX15IAPPKAT8PPARA | |
| SCHEMBL11721061 | 0.98 | IGF1R (0.76) | IGF1RALOX15IAPPKAT8PPARA | |
| SCHEMBL30451791 | 0.98 | IGF1R (0.76) | IGF1RALOX15IAPPKAT8PPARA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 68 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10202474-B2 | Process for producing polydienes | BRIDGESTONE CORPORATION (JP) | 2019-02-12 | — | — | US | claimed |
| US-20170073443-A1 | PROCESS FOR PRODUCING POLYDIENES | BRIDGESTONE CORPORATION (US) | 2017-03-16 | — | — | US | claimed |
| US-4894139-A | Methods for deactivating copper in hydrocarbon fluids | BETZ LABORATORIES, INC. (US) | 1990-01-16 | — | — | US | claimed |
| US-12473454-B2 | Water-based extrusion primer for polyethylene | HENKEL AG & CO. KGAA (DE) | 2025-11-18 | — | — | US | disclosed |
| US-12227668-B2 | Use of preformed reaction products of catechol compounds and functionalized co-reactant compounds to reduce oxidation of bare metal surfaces | HENKEL AG & CO. KGAA (DE) | 2025-02-18 | — | — | US | disclosed |
| EP-3559312-B1 | REACTION PRODUCTS OF CATECHOL COMPOUNDS AND FUNCTIONALIZED CO-REACTANT COMPOUNDS FOR METAL PRETREATMENT APPLICATIONS | HENKEL AG & CO KGAA (DE) | 2024-04-24 | — | — | EP | disclosed |
| EP-3558667-B1 | TREATMENT OF CONVERSION-COATED METAL SUBSTRATES WITH PREFORMED REACTION PRODUCTS OF CATECHOL COMPOUNDS AND FUNCTIONALIZED CO-REACTANT COMPOUNDS | HENKEL AG & CO KGAA (DE) | 2024-03-20 | — | — | EP | disclosed |
| US-11891534-B2 | Treatment of conversion-coated metal substrates with preformed reaction products of catechol compounds and functionalized co-reactant compounds | HENKEL AG & CO. KGAA (DE) | 2024-02-06 | — | — | US | disclosed |
| US-11576413-B2 | Compositions comprising ionized cannabidiol | Natural Extraction Systems, LLC (US) | 2023-02-14 | — | — | US | disclosed |
| CN-113454174-B | Water-based extrusion primer for polyethylene | 汉高股份有限及两合公司 | 2023-01-24 | — | — | CN | disclosed |
| CN-110100045-B | Reaction products of catechol compounds with functionalized co-reactive compounds for metal pretreatment applications | 汉高股份有限及两合公司 | 2022-09-06 | — | — | CN | disclosed |
| EP-0962439-A1 | Process and apparatus for producing dihydric phenolic compound | UBE INDUSTRIES, LTD. (JP) | 1999-12-08 | — | — | EP | disclosed |
| EP-0954297-A1 | USE OF BISPHENOLIC COMPOUNDS TO TREAT TYPE II DIABETES | SHAMAN PHARMACEUTICALS, INC. (US) | 1999-11-10 | — | — | EP | disclosed |
| WO-1998015266-A1 | USE OF BISPHENOLIC COMPOUNDS TO TREAT TYPE II DIABETES | SHAMAN PHARMACEUTICALS, INC. (US) | 1998-04-16 | — | — | WO | disclosed |
| US-5214034-A | Improved secretion of nerve growth factor | MITSUI TOATSU CHEMICALS, INCORPORATED (JP) | 1993-05-25 | — | — | US | disclosed |
| US-5102906-A | Alzheimer*s disease | MITSUI TOATSU CHEMICALS, INCORPORATED (JP) | 1992-04-07 | — | — | US | disclosed |
| EP-0261977-B1 | CATECHOL DERIVATIVES, AND PREVENTIVE AND REMEDIAL PREPARATIONS FOR REGRESSIVE DISORDERS IN THE CENTRAL NERVOUS SYSTEM | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1992-03-04 | — | — | EP | disclosed |
| US-4985458-A | TREATMENT OF ALZHEIMER*S DISEASE | MITSUI TOATSU CHEMICALS, INCORPORATED (JP) | 1991-01-15 | — | — | US | disclosed |
| EP-0261977-A2 | Catechol derivatives, and preventive and remedial preparations for regressive disorders in the central nervous system | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1988-03-30 | — | — | EP | disclosed |
| US-3997565-A | METAL COMPLEXING AGENT, DISPERSANT, CARBON BLACK, VIRICIDE | E. I. DU PONT DE NEMOURS AND COMPANY (US) | 1976-12-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11576413-B2 | Compositions comprising ionized cannabidiol | CNR1, CNR2, PLCB3 | IGF1R 3161/4885ALOX15 811/4885IAPP 1778/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.